CD59 and renal carcinoma: In fact, Blok et al. demonstrated that the expression of CD46 and CD59 is downregulated by interleukin-1β, the expression of CD46 is downregulated by IL-4, and that of CD46 and CD55 is downregulated by TGF-β1 in renal cancer cells56.